Membrane Chemicals Market Size & Share 2026-2035

Membrane Chemicals Market Size

The global membrane chemicals market was valued at USD 2.6 billion in 2025, up from USD 2.5 billion in 2024. From USD 2.7 billion in 2026, it is projected to reach USD 4.9 billion by 2035, expanding at approximately 6.5% CAGR.Growth is tied to the operating requirements of desalination, wastewater reuse, high-purity industrial water, and produced-water treatment systems rather than to one-time membrane-equipment sales.

Membrane chemicals include antiscalants and scale inhibitors, cleaning chemicals, coagulants and flocculants, pH adjusters and buffers, biocides and disinfectants, dechlorination agents, boron removal chemicals, corrosion inhibitors, and antifoaming agents. Their consumption is determined by feedwater composition, recovery targets, membrane configuration, fouling risk, and clean-in-place schedules. In reverse osmosis (RO), particularly seawater RO, chemical programs are integral to preserving flux, preventing mineral precipitation, neutralizing oxidants before polyamide membranes, and maintaining product-water quality.

The market expanded from USD 2,310 million in 2022 to USD 2,400 million in 2023 and USD 2,500 million in 2024. That progression reflects both new desalination commissioning and wider use of membrane trains in industrial reuse, power generation, oilfield water management, pharmaceuticals, and semiconductor manufacturing. Regulatory qualification requirements, including NSF/ANSI 60 and European drinking-water-contact rules, further distinguish membrane chemicals from undifferentiated bulk water-treatment inputs.

The market's growth is increasingly shaped by feedwater difficulty rather than membrane area alone. High-salinity seawater, wastewater reuse, silica-rich brines, and hydrocarbon-contaminated produced water require more specialized dosing and diagnostics than conventional low-recovery systems. Chemical suppliers that combine formulations with monitoring, membrane autopsies, and operating support are therefore better positioned to defend value than suppliers competing solely on delivered chemical price.

Key Drivers

Rising demand for desalination in water-scarce regions

Desalination expansion directly increases demand for membrane chemicals because RO installations require continuous scale control, oxidant management, biological-fouling control, and cleaning. The European Commission identifies desalination as an expanding component of water-security investment, particularly across Mediterranean and water-stressed markets, where RO has become the principal technology for new capacity because of its energy and operational advantages over thermal alternatives ^{[1]European Commission Blue Economy Observatory, blue-economy-observatory.ec.europa.eu}. The concentration of desalination capacity in MENA also makes the region a major center of procurement for seawater-compatible antiscalants, biocides, and cleaning programs.

The commercial consequence is more significant than rising membrane element volumes alone. Larger seawater RO facilities operate against elevated salinity, seasonal biological loading, and stringent permeate specifications; these conditions increase the importance of chemical selection, dose verification, and responsive cleaning protocols. Chemical suppliers that can demonstrate lower differential-pressure growth or longer intervals between cleanings can compete on lifecycle performance rather than unit price.

Increasing industrial water treatment requirements

Industrial membrane adoption is being reinforced by discharge controls and by demand for reuse-quality water. In the United States, the EPA's Effluent Guidelines establish technology-based requirements for industrial wastewater discharges, creating a compliance rationale for membrane pretreatment and polishing in affected facilities ^{[2]U.S. Environmental Protection Agency, epa.gov}. In Europe, Commission Delegated Regulation (EU) 2024/370 introduced conformity assessment requirements for products used in contact with water intended for human consumption, increasing traceability and qualification requirements for water-treatment chemicals.

Industrial applications also impose higher technical demands than conventional municipal treatment. Pharmaceutical operations require controlled water quality for purified water and water-for-injection systems, while semiconductor facilities use multi-stage treatment to protect ultrapure-water production. MBR systems are increasingly used where compact treatment footprints and high-quality effluent justify more intensive anti-fouling and cleaning programs. In high-recovery desalination systems, mineral scaling can materially alter process economics, making pretreatment optimization an operational priority rather than a routine purchasing decision.

Government investments in sustainable water infrastructure

Public funding is extending the installed base of reuse and desalination infrastructure. In January 2025, the U.S. Department of the Interior announced more than USD 223 million for 18 water recycling and desalination projects, expected to provide 305,936 acre-feet of recycled water annually. The U.S. Department of Energy also announced USD 75 million for the second phase of the National Alliance for Water Innovation, supporting lower-cost and lower-energy water purification technologies.

Project-level investment creates multiyear chemical demand after construction is complete. The Texas Water Development Board approved USD 535.1 million for Corpus Christi's Inner Harbor Ship Channel desalination project in July 2024; the facility is designed to produce 20 million gallons per day, with potential expansion to 30 million gallons per day. Such projects create an enduring installed base for antiscalants, dechlorination agents, cleaners, and monitoring-linked chemical services.

Key Restraints

High operational costs of membrane chemical treatment

Chemical expenditure is a persistent operating-cost consideration for membrane-system owners, especially where procurement budgets are constrained. A 2024 comparison of conventional and ultrafiltration drinking-water treatment found chemical use to be a meaningful component of treatment economics, even where membrane treatment offers operational benefits. At high recovery, the cost sensitivity becomes more acute because scaling and precipitation risk rise sharply as brines concentrate.

This pressure does not eliminate demand for membrane chemistry; it changes purchasing behavior. Municipal operators and smaller industrial facilities may favor lower-priced formulations, reduce cleaning frequency, or defer specialist diagnostic support. Suppliers must therefore demonstrate the avoided cost of premature membrane replacement, lost permeate production, elevated energy consumption, and unplanned shutdowns if they are to sustain premium pricing.

Limited technical expertise for advanced membrane maintenance

The value of a membrane chemical program depends on correct diagnosis and execution. Operators must distinguish among carbonate, sulfate, silica, colloidal, organic, and biological fouling before selecting cleaners or adjusting antiscalant programs. Misapplied chemistry can shorten membrane life, increase energy requirements, and create avoidable cleaning downtime.

The constraint is most visible in smaller utilities and emerging-market industrial sites that lack laboratory capability, membrane-autopsy access, or experienced process personnel. It limits adoption of higher-value formulations even where new membrane assets are being installed. Technical service, remote normalization, and site-specific dosing support can mitigate this limitation, but they also increase the cost and complexity of the supplier relationship. GMI Analyst View

The main market tension is not whether membrane chemicals are necessary, but how much performance assurance operators are willing to purchase. Capital-backed desalination and reuse projects establish a growing installed base, while operating budgets create pressure to lower dose rates and simplify chemical programs. That tension favors suppliers able to convert operating data into credible total-cost-of-ownership outcomes.

Technical capability is becoming a competitive boundary. A supplier that provides membrane autopsies, performance normalization, and responsive cleaning recommendations can reduce uncertainty for plant operators and protect chemical-program value. The resulting shift toward service-linked chemistry is likely to separate specialist providers from suppliers offering formulations without application support.

Membrane Chemicals Market Segment Analysis

By Type

Antiscalants & Scale Inhibitors represented the largest type segment, valued at USD 739.6 million in 2025 and projected to reach USD 1,409.4 million by 2035 at approximately 6.8% CAGR. The category includes Phosphonates, such as HEDP, ATMP, and PBTC; Polycarboxylates, including polyacrylates and polymaleates; and Fluorescent-Tagged Antiscalants. These products inhibit crystallization and disperse precipitates that would otherwise impair RO and NF membranes. Kemira's KemGuard and phosphorus-free KemEguard product platforms illustrate the industry's response to both performance and environmental-discharge requirements ^{[3]Kemira, kemira.com}.

Cleaning Chemicals were valued at USD 582.3 million in 2025 and are projected to reach USD 1,117.8 million by 2035 at approximately 6.9% CAGR. Acid Cleaners remove inorganic scale and metal deposits; Alkaline Cleaners address organic and colloidal foulants; Oxidizing Cleaners are used particularly in UF and MBR systems; and Enzymatic Cleaners target biological and organic foulants in applications where material compatibility and residue control are important. Lower cleaning frequency can reduce operating expenditure, but only when membrane protection and fouling control are maintained.

Coagulants & Flocculants reached USD 385.5 million in 2025 and are projected to reach USD 670.7 million by 2035. Inorganic Coagulants such as ferric chloride, alum, and PAC, together with Organic Polymers including cationic, anionic, and non-ionic polyacrylamides, condition feedwater before membrane contact. Their value lies in lowering suspended-solids loading and reducing the downstream burden on membrane cleaning programs.

pH Adjusters & Buffers accounted for USD 304.9 million in 2025 and are projected to reach USD 510.3 million by 2035. Acid Additions including sulfuric acid, hydrochloric acid, and carbon dioxide suppress carbonate scaling, while Base Additions such as sodium hydroxide, sodium carbonate, and lime support boron-rejection and post-treatment requirements. Boron-removal performance improves when boric acid is converted to more readily rejected borate species at elevated pH.

Biocides & Disinfectants were valued at USD 265.0 million in 2025 and are projected to reach USD 510.3 million by 2035 at approximately 6.9% CAGR. Oxidizing Biocides include chlorine, chlorine dioxide, hydrogen peroxide, and peracetic acid; Non-oxidizing Biocides include isothiazolinones, DBNPA, and quaternary ammonium compounds. Polyamide RO systems require especially careful oxidant control because chlorine exposure can cause irreversible damage.

Dechlorination Agents are projected to be the fastest-growing type segment, advancing from USD 151.3 million in 2025 to USD 330.5 million in 2035 at approximately 8.3% CAGR. Sodium bisulfite and sodium metabisulfite remain standard methods for neutralizing oxidant residuals before polyamide membranes. No-chlorine and no-SBS operating designs have been evaluated in Arabian Gulf RO conditions, but conventional chlorination followed by dechlorination remains the established commercial approach.

Boron Removal Chemicals were valued at USD 68.3 million in 2025 and are projected to reach USD 145.8 million by 2035. The segment comprises Ion Exchange Resins, Electrodeionization, and pH Elevation Chemicals. Boron is difficult to remove with standard RO at seawater pH because boric acid is largely uncharged; ion exchange and second-pass RO at higher pH are used where potable-water or irrigation requirements demand lower boron concentrations.

Corrosion Inhibitors accounted for USD 55.3 million in 2025 and are projected to reach USD 58.3 million by 2035 at approximately 0.7% CAGR. Phosphate-Based Inhibitors, Silicate-Based Inhibitors, and Organic Inhibitors remain relevant in legacy assets and supporting utility systems, although corrosion-resistant construction materials moderate growth.

Antifoaming Agents were valued at USD 35.8 million in 2025 and are projected to reach USD 48.6 million by 2035. Silicone-based and mineral-oil defoamers are used in aeration, dissolved-air flotation, and chemical-mixing stages where foam can disrupt pretreatment consistency.

By Technology

Reverse Osmosis (RO) was the largest technology segment at USD 1,749.3 million in 2025, or approximately 67% of the market, and is projected to reach USD 3,207.6 million by 2035. RO's scale reflects its central role in desalination and water purification. The United Nations identifies membrane desalination as the dominant technology family in global desalination deployment ^{[4]United Nations World Ocean Assessment, woa.un.org}. SWRO installations require intensive chemical control because elevated salinity, biological loading, and recovery targets increase scaling and fouling exposure. BWRO supports potable-water and industrial-water treatment in inland water-stressed regions.

Thermal Desalination (MSF/MED) represented USD 465.4 million in 2025 and is projected to reach USD 826.2 million by 2035. While new desalination capacity increasingly favors RO, the installed thermal base in Gulf markets sustains demand for high-temperature antiscalants, corrosion inhibitors, oxygen scavengers, and descaling products.

Nanofiltration (NF) accounted for USD 101.6 million in 2025 and is projected to reach USD 170.1 million by 2035. NF is used for hardness reduction, divalent-ion separation, and removal of selected natural-organic-matter fractions. Its lower operating pressure reduces chemical intensity relative to RO, but scale control and cleaning remain necessary.

Hybrid Systems (NF-RO, HPRO, OARO, FO) were valued at USD 68.3 million in 2025 and are projected to reach USD 145.8 million by 2035 at approximately 8.0% CAGR. These systems target high-salinity produced water, brine concentration, and zero-liquid-discharge applications. Research on zero- and minimal-liquid-discharge desalination indicates that higher recovery is achievable but carries substantially higher energy and chemical-management demands than conventional RO.

Ultrafiltration (UF) & Microfiltration (MF) represented USD 133.9 million in 2025 and are projected to reach USD 267.3 million by 2035. UF and MF commonly protect downstream RO systems by reducing solids, turbidity, and biological loading. Their chemical requirement is concentrated in coagulation support, backwash, hypochlorite control, and acidic or alkaline cleaning. Facility-level studies have identified cleaning chemicals as a meaningful component of membrane-treatment costs.

Membrane Bioreactor (MBR) chemicals were valued at USD 57.5 million in 2025 and are projected to reach USD 145.8 million by 2035 at approximately 9.9% CAGR. MBR systems combine biological treatment and membrane separation to produce high-quality effluent in a compact footprint. Their fouling conditions support demand for cleaners, coagulants, antifoaming products, and biological-control chemistry, particularly in municipal reuse and industrial effluent applications.

By End User

Municipal Corporation was the dominant end-user category at USD 1,368.4 million in 2025 and is projected to reach USD 2,575.8 million by 2035. Seawater Desalination drives high-intensity continuous chemical consumption, while Brackish Water Desalination expands the installed base across inland and coastal water-stressed communities. European conformity requirements for products in contact with drinking water raise documentation and qualification requirements for chemical suppliers.

Oil & Gas Industry accounted for USD 477.5 million in 2025 and is projected to reach USD 923.4 million by 2035. Enhanced Oil Recovery (EOR), Produced Water Treatment, and Offshore Platform Water Treatment each require chemical programs that account for high salinity, barium and strontium scaling risk, hydrocarbons, iron, and remote-site supply constraints.

Petrochemicals & Refining represented USD 372.7 million in 2025 and are projected to reach USD 729.0 million by 2035. These facilities use membrane systems for process-water treatment, cooling, boiler feedwater, and reuse. Ecolab's water-management portfolio combines membrane treatment chemistry with monitoring and control tools, illustrating the shift toward integrated chemical-management models in complex industrial accounts.

Power Generation accounted for USD 203.2 million in 2025 and is projected to reach USD 340.2 million by 2035. Demand is associated with boiler-feedwater purification and cooling-water management, although the segment's approximately 5.4% CAGR is below the market average.

Industrial Water Treatment was valued at USD 147.1 million in 2025 and is projected to reach USD 218.7 million by 2035. The category includes Pharmaceuticals, Food & Beverages, Textiles, and Mining (Phosphate). Pharmaceutical water systems carry particularly demanding cleaning and sanitation requirements, while mining applications use RO and NF to recycle process water and manage water supply in arid operating environments.

MBR, hybrid systems, boron removal, and produced-water treatment create a second, higher-value pathway. In these applications, membrane underperformance can affect discharge compliance, product-water quality, recovery economics, or upstream production continuity. Faster-growing specialty segments therefore offer suppliers an opportunity to capture value through application engineering, diagnostics, and tailored chemistry rather than through bulk chemical volume alone.

Membrane Chemicals Market Regional Analysis

North America

North America was valued at USD 715.3 million in 2025 and is projected to reach USD 1,224.7 million by 2035 at approximately 5.7% CAGR. The United States represented USD 595.8 million in 2025. Demand is supported by aging drinking-water infrastructure, industrial reuse, desalination in the Southwest, and PFAS-related treatment upgrades. The EPA estimated that U.S. drinking-water infrastructure would require USD 472.6 billion in investment over 20 years, supporting continued treatment-system renewal ^{[5]Congressional Research Service, congress.gov}. Federal desalination and reuse programs administered by the Bureau of Reclamation also support membrane deployment. Canada contributes demand from oil sands treatment, mining, and municipal systems.

Europe

Europe was the largest regional market at USD 956.3 million in 2025 and is projected to reach USD 1,812.8 million by 2035. Spain's substantial desalination infrastructure, Mediterranean municipal demand, and industrial treatment activity in Germany, France, Italy, Cyprus, Greece, Malta, and the United Kingdom underpin the region's position. European drinking-water rules create a commercially important barrier to entry because chemical suppliers must demonstrate conformity for products used in contact with water intended for human consumption. Kemira has identified the Urban Wastewater Treatment Directive, the revised Drinking Water Directive, phosphorus-removal obligations, and PFAS regulation as demand catalysts for advanced water-treatment chemistry.

Asia Pacific

Asia Pacific was valued at USD 615.7 million in 2025 and is projected to reach USD 1,161.5 million by 2035. China leads regional demand through coastal industrial activity, semiconductor manufacturing, petrochemicals, and power generation. India is the fastest-growing country market, supported by municipal supply infrastructure, industrial reuse, and desalination activity in Tamil Nadu and Gujarat. Japan and South Korea maintain high chemical intensity in ultrapure-water systems serving semiconductor, electronics, pharmaceutical, and power-sector applications. Australia's municipal SWRO assets in Perth, Adelaide, and Sydney provide recurring demand during drought-driven supply constraints.

Latin America

Latin America was valued at USD 204.4 million in 2025 and is projected to reach USD 432.5 million by 2035 at approximately 7.9% CAGR. Brazil's industrial base, Mexico's manufacturing and coastal desalination activity, and Chile's mining-linked seawater treatment are the principal growth drivers. Chilean copper, lithium, and phosphate operations increasingly depend on desalinated seawater where inland freshwater availability is constrained. In this setting, membrane chemical reliability has a direct connection to mineral-processing continuity and water-supply security.

Middle East and Africa

Middle East and Africa represented USD 128.4 million in 2025 and are projected to reach USD 228.4 million by 2035. Saudi Arabia, the UAE, Qatar, and Kuwait maintain the region's most concentrated desalination-related chemical demand because of their large SWRO and thermal-desalination fleets. H2O Innovation supplies its phosphate-free SpectaGuard 100 antiscalant to the Taweelah SWRO plant in the UAE through DUTCO; the facility has 909,200 m³/day of capacity ^{[6]H2O Innovation Inc., h2oinnovation.com}. Veolia's SIDEM subsidiary is engineering the Hassyan SWRO project in Dubai, designed for 2.9 kWh/m³ energy intensity, reinforcing the importance of pretreatment and membrane-protection programs in energy-efficient desalination design. Africa remains a smaller market, with demand concentrated in South Africa, Nigeria, and Algeria.

Asia Pacific, Latin America, and the Middle East and Africa are more dependent on new capacity commissioning, particularly desalination and industrial-water projects. Latin America's higher projected growth rate reflects a low base combined with mining-related desalination, water reuse, and tighter industrial-water practices. MENA remains the strategic volume center for seawater-compatible chemistry, where the performance consequences of scaling or biofouling in very large plants can outweigh small differences in delivered chemical cost.

Membrane Chemicals Market Share & Competitive Landscape

The market is moderately fragmented. Large water-treatment and specialty-chemical companies compete across multiple product categories, while focused membrane-chemistry suppliers compete through RO-specific formulations, application knowledge, and distributor networks. Performance verification, drinking-water approvals, membrane-manufacturer compatibility, logistics reliability, and technical support are major purchasing criteria.

Kurita Water Industries Ltd. combines water-treatment chemicals and equipment. Its 2019 acquisition of Avista Technologies expanded its RO chemical capabilities, while KURIVERTER and KURIDYNE product lines address pretreatment, slime control, foulant dispersion, cleaning, and membrane rejuvenation ^{[7]J-STAGE, jstage.jst.go.jp}. Its chemical supply, membrane recycling, and field-support model positions the company as a membrane-management provider rather than solely a formulation vendor.

Genesys manufactures RO antiscalants, cleaners, flocculants, and biocides, including the Genesys and Genesol product families. Its NSF-certified product portfolio supports drinking-water applications, while its membrane-autopsy and dosing-modeling capabilities reinforce a diagnostic-led service proposition.

Kemira supplies antiscalants, coagulants, flocculants, and biocides for membrane and thermal desalination. Its KemGuard and KemEguard ranges address conventional and phosphorus-free antiscalant requirements. Kemira also acquired Norit's UK activated-carbon reactivation operations in 2024, widening its addressable water-treatment portfolio.

Lenntech B.V. supplies water-treatment equipment, membrane-separation technologies, ion-exchange resins, EDI modules, and chemicals. Its turnkey engineering capabilities allow the company to link chemical selection with process design for industrial and municipal customers.

Reverse Osmosis Chemicals International supplies RO cleaners, scale inhibitors, antiscalants, corrosion inhibitors, biocides, dechlorinators, and flocculants for desalination and RO applications. Its competitive position rests on RO-specific formulation and technical-support capability.

King Lee Technologies supplies Pretreat Plus antiscalants, membrane cleaners, preservation chemicals, and microbiological-control products. Its iWaterPRO platform supports membrane normalization, CIP scheduling, and dosing calculations, extending its role into operating-data management.

H2O Innovation participates through its Specialty Products division, including Genesys and PWT product lines. Its SpectaGuard 100 phosphate-free antiscalant at Taweelah demonstrates its ability to support large SWRO facilities with specialized chemistry.

Veolia markets Hydrex membrane-treatment formulations, including antiscalants, biocontrol additives, membrane-storage products, and cleaners. Its OPUS treatment approach integrates pretreatment, ion exchange, and RO for difficult industrial feedwaters.

Universal Water Chemicals Pvt Ltd supplies RO antiscalants, acid and alkaline membrane cleaners, effluent-treatment chemicals, cooling-tower chemicals, and boiler-treatment chemicals, alongside RO, STP, and ETP system services in India.

LK Chemicals participates in the membrane chemicals market through antiscalants, cleaning chemicals, and related treatment products for industrial and municipal RO and NF applications.

Thermax Limited supplies water and waste solutions, including MBR, electrodialysis reversal, zero-liquid-discharge systems, seawater desalination, and modular RO systems. Its Tulsion ion-exchange resins support high-purity-water and specialized separation applications.

Ecolab Inc. reported Global Water revenue of USD 7,483.4 million in 2024 ^{[8]Ecolab Inc., sec.gov}. Its membrane-treatment, scale-control, antifoulant, pretreatment, coagulation, flocculation, and anti-foam portfolio is supported by 3D TRASAR monitoring and control technology.

Solenis LLC supplies industrial water-treatment programs, biocides, process aids, and monitoring systems. Its global operating footprint and water-treatment heritage support supply relationships across refineries, chemical plants, wastewater facilities, and municipal systems.

Recent Industry Developments

H2O Innovation Extends Taweelah Antiscalant Supply Contract - December 2024

H2O Innovation expanded and extended its SpectaGuard 100 antiscalant supply agreement for the Taweelah SWRO facility in the UAE. The agreement, managed through DUTCO Tenant LLC, continues the company's role as the sole RO membrane antiscalant supplier to the 909,200 m³/day facility.

Kemira Expands into Activated Carbon - June 2024

Kemira acquired Norit's UK activated-carbon reactivation operations, adding activated-carbon capability for taste, odor, and micropollutant removal to its water-treatment portfolio.

Texas Water Development Board Approves Corpus Christi Desalination Financing - July 2024

The Texas Water Development Board approved USD 535.1 million in financing for Corpus Christi's Inner Harbor Ship Channel desalination project. The proposed plant is designed for 20 million gallons per day, with expansion potential to 30 million gallons per day.

European Commission Implements Water-Contact Product Conformity Requirements - January 2024

Commission Implementing Decision (EU) 2024/368 established requirements associated with the hygiene and conformity assessment of materials and products that contact water intended for human consumption under Directive (EU) 2020/2184.

DuPont Announces Sinochem (Ningbo) RO Memtech Acquisition Agreement - September 2025

DuPont announced an agreement to acquire Sinochem (Ningbo) RO Memtech, adding a FilmTec RO membrane manufacturing location in Zhejiang, China. The transaction is intended to expand manufacturing capacity serving industrial water purification and reuse demand in Asia Pacific.

LG Chem Completes Water Filter Division Sale - June 2025

LG Chem completed the sale of its water-filter division to Glenwood Private Equity for approximately USD 1 billion. The division generated KRW 220 billion in 2024 revenue, and the transaction reflects continuing ownership change among major RO membrane suppliers.

Veolia Advances Hassyan SWRO Project in the UAE

Veolia's SIDEM subsidiary was selected to engineer and supply key technology for the Hassyan seawater desalination project in Dubai. The project is designed for 2.9 kWh/m³ energy intensity and incorporates advanced pretreatment and post-treatment processes.